Cargando…

Immune-related pneumonitis with nivolumab and ipilimumab during the coronavirus disease 2019 (COVID-19) pandemic

Detalles Bibliográficos
Autores principales: Souza, Ive L., Fernandes, Ítalo, Taranto, Patrícia, Buzaid, Antonio C., Schvartsman, Gustavo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7298497/
https://www.ncbi.nlm.nih.gov/pubmed/32585589
http://dx.doi.org/10.1016/j.ejca.2020.06.004
_version_ 1783547218615074816
author Souza, Ive L.
Fernandes, Ítalo
Taranto, Patrícia
Buzaid, Antonio C.
Schvartsman, Gustavo
author_facet Souza, Ive L.
Fernandes, Ítalo
Taranto, Patrícia
Buzaid, Antonio C.
Schvartsman, Gustavo
author_sort Souza, Ive L.
collection PubMed
description
format Online
Article
Text
id pubmed-7298497
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Elsevier Ltd.
record_format MEDLINE/PubMed
spelling pubmed-72984972020-06-17 Immune-related pneumonitis with nivolumab and ipilimumab during the coronavirus disease 2019 (COVID-19) pandemic Souza, Ive L. Fernandes, Ítalo Taranto, Patrícia Buzaid, Antonio C. Schvartsman, Gustavo Eur J Cancer Letter to the Editor Elsevier Ltd. 2020-08 2020-06-17 /pmc/articles/PMC7298497/ /pubmed/32585589 http://dx.doi.org/10.1016/j.ejca.2020.06.004 Text en © 2020 Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Letter to the Editor
Souza, Ive L.
Fernandes, Ítalo
Taranto, Patrícia
Buzaid, Antonio C.
Schvartsman, Gustavo
Immune-related pneumonitis with nivolumab and ipilimumab during the coronavirus disease 2019 (COVID-19) pandemic
title Immune-related pneumonitis with nivolumab and ipilimumab during the coronavirus disease 2019 (COVID-19) pandemic
title_full Immune-related pneumonitis with nivolumab and ipilimumab during the coronavirus disease 2019 (COVID-19) pandemic
title_fullStr Immune-related pneumonitis with nivolumab and ipilimumab during the coronavirus disease 2019 (COVID-19) pandemic
title_full_unstemmed Immune-related pneumonitis with nivolumab and ipilimumab during the coronavirus disease 2019 (COVID-19) pandemic
title_short Immune-related pneumonitis with nivolumab and ipilimumab during the coronavirus disease 2019 (COVID-19) pandemic
title_sort immune-related pneumonitis with nivolumab and ipilimumab during the coronavirus disease 2019 (covid-19) pandemic
topic Letter to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7298497/
https://www.ncbi.nlm.nih.gov/pubmed/32585589
http://dx.doi.org/10.1016/j.ejca.2020.06.004
work_keys_str_mv AT souzaivel immunerelatedpneumonitiswithnivolumabandipilimumabduringthecoronavirusdisease2019covid19pandemic
AT fernandesitalo immunerelatedpneumonitiswithnivolumabandipilimumabduringthecoronavirusdisease2019covid19pandemic
AT tarantopatricia immunerelatedpneumonitiswithnivolumabandipilimumabduringthecoronavirusdisease2019covid19pandemic
AT buzaidantonioc immunerelatedpneumonitiswithnivolumabandipilimumabduringthecoronavirusdisease2019covid19pandemic
AT schvartsmangustavo immunerelatedpneumonitiswithnivolumabandipilimumabduringthecoronavirusdisease2019covid19pandemic